EVK [Ever-Glory International,] 10-K: EVER-GLORY INTERNATIONAL GROUP, INC. FORM 10-K For the

[EVER-GLORY INTERNATIONAL GROUP, INC. FORM 10-K For the Year Ended December 31, 2009 TABLE OF CONTENTS Part I 4] [SUBSIDIARIES Perfect Dream Limited, a corporation established under the laws of the British Virgin Islands Goldenway Nanjing Garments Co., Ltd, a wholly foreign-owned limited liability company formed under the laws of the People's Republic of China Nanjing Catch-Luck Garments Co., Ltd., a wholly foreign-owned limited liability company formed under the laws of the People’s Republic of China Nanjing New-Tailun Garments] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Edward Yihua Kang, certify that: 1. I have reviewed this annual report on Form 10-K of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Yan Guo, certify that: 1. I have reviewed this annual report on Form 10-K of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Edward Yihua Kang Edward Yihua Kang Chief Executive Officer EX-32.1 6 v179237_ex32-1.htm] [OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Yan Guo Yan Guo Chief Finance Officer (Principal Finance Officer) EX-32.2 7 v179237_ex32-2.htm]

By | 2016-03-02T18:07:10+00:00 March 31st, 2010|Categories: Chinese Stocks, EVK, Webplus ver|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-K: (Original Filing)

[FORM 10-K  For the fiscal year ended December 31, 2009 OR  For the transition period from ________________ to ________________ 001-15643 SKYSTAR BIO-PHARMACEUTICAL COMPANY Nevada 33-0901534 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian Province, P.R. China N/A (Zip Code) (8629) 8819-3188 Title of] [SERVICES AGREEMENT This SERVICES AGREEMENT (this “Agreement”), dated as of March 30, 2010, by and between Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), and R. Scott Cramer, an individual, whose address is 1012 Lewis Drive Winter Park, Florida 32789-2225 (“Consultant”). The Company and the Consultant are collectively referred to herein as the “Parties.” RECITALS: A. B. NOW, THEREFORE, in] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bennet P. Tchaikovsky, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer March 31, 2010 EX-32.1 9 v179475_ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Bennet P. Tchaikovsky Chief Financial Officer March 31, 2010 EX-32.2 10 v179475_ex32-2.htm] [Contract Registration No. 20096101021102 Technical Cooperation Agreement Name of Project: Cooperative Research of Party A: Xian Tianxing Bio-Pharmaceutical Co., Ltd. (stamp) Party B: Fourth Military Medical University (stamp) China Place of Execution: Xi’an, Shaanxi Province, China Date of Effective: September 23, 2009 Term of Validity: From September 23, 2009 to the date when the performances under the terms of the]

By | 2016-03-01T06:24:36+00:00 March 31st, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-K: FORM 10-K  For the fiscal year ended

[FORM 10-K  For the fiscal year ended December 31, 2009 OR  For the transition period from ________________ to ________________ 001-15643 SKYSTAR BIO-PHARMACEUTICAL COMPANY Nevada 33-0901534 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian Province, P.R. China N/A (Zip Code) (8629) 8819-3188 Title of] [SERVICES AGREEMENT This SERVICES AGREEMENT (this “Agreement”), dated as of March 30, 2010, by and between Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), and R. Scott Cramer, an individual, whose address is 1012 Lewis Drive Winter Park, Florida 32789-2225 (“Consultant”). The Company and the Consultant are collectively referred to herein as the “Parties.” RECITALS: A. B. NOW, THEREFORE, in] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bennet P. Tchaikovsky, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer March 31, 2010 EX-32.1 9 v179475_ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Bennet P. Tchaikovsky Chief Financial Officer March 31, 2010 EX-32.2 10 v179475_ex32-2.htm] [Contract Registration No. 20096101021102 Technical Cooperation Agreement Name of Project: Cooperative Research of Party A: Xian Tianxing Bio-Pharmaceutical Co., Ltd. (stamp) Party B: Fourth Military Medical University (stamp) China Place of Execution: Xi’an, Shaanxi Province, China Date of Effective: September 23, 2009 Term of Validity: From September 23, 2009 to the date when the performances under the terms of the]

By | 2016-03-01T06:25:29+00:00 March 31st, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More

THTI [THT Heat Transfer Technology] 10-K: (Original Filing)

[FORM 10-K 000-52232 THT HEAT TRANSFER TECHNOLOGY, INC. Nevada 20-5463509 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) THT Industrial Park, 86-434-3265241 (Former name, former address and former fiscal year, if changed since last report) Large accelerated filer [ ] Accelerated filer [ ] (Do not check if a smaller reporting company) Non-accelerated filer [ ]] [Certification I, Guohong Zhao, certify that: 1. I have reviewed this annual report on Form 10-K of THT Heat Transfer Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [Certification I, Jianjun He, certify that: 1. I have reviewed this annual report on Form 10-K of THT Heat Transfer Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Guohong Zhao Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jianjun He Chief Financial Officer (Principal Financial Officer)]

By | 2016-03-22T21:13:16+00:00 March 31st, 2010|Categories: Chinese Stocks, SEC Original, THTI|Tags: , , , , , |0 Comments
Read More

THTI [THT Heat Transfer Technology] 10-K: FORM 10-K 000-52232 THT HEAT TRANSFER TECHNOLOGY, INC.

[FORM 10-K 000-52232 THT HEAT TRANSFER TECHNOLOGY, INC. Nevada 20-5463509 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) THT Industrial Park, 86-434-3265241 (Former name, former address and former fiscal year, if changed since last report) Large accelerated filer [ ] Accelerated filer [ ] (Do not check if a smaller reporting company) Non-accelerated filer [ ]] [Certification I, Guohong Zhao, certify that: 1. I have reviewed this annual report on Form 10-K of THT Heat Transfer Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [Certification I, Jianjun He, certify that: 1. I have reviewed this annual report on Form 10-K of THT Heat Transfer Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Guohong Zhao Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jianjun He Chief Financial Officer (Principal Financial Officer)]

By | 2016-03-22T21:14:42+00:00 March 31st, 2010|Categories: Chinese Stocks, THTI, Webplus ver|Tags: , , , , , |0 Comments
Read More

KNDI [Kandi Technologies] 10-K: (Original Filing)

[TABLE OF CONTENTS PART I Item 1. Business. 1-4] [EX-23.1 2 v179305_ex23-1.htm] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors of Kandi Technologies, Corp. WEINBERG & COMPANY, P.A. Certified Public Accountants Boca Raton, Florida March 31, 2010 EX-23.2 4 v179305_ex23-2.htm] [I, Hu Xiaoming, certify that: 1. I have reviewed this annual report on Form 10-K of Kandi Technologies, Corp. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [I, Zhu Xiaoying, certify that: 1. I have reviewed this annual report on Form 10-K of Kandi Technologies, Corp. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Hu Xiaoming President and Chief Executive Officer Zhu Xiaoying Chief Financial Officer March 31, 2010 EX-32.1 7 v179305_ex32-1.htm]

By | 2016-03-18T17:14:16+00:00 March 31st, 2010|Categories: Chinese Stocks, KNDI, SEC Original|Tags: , , , , , |0 Comments
Read More

DHRM [Dehaier Medical Systems] 10-K: (Original Filing)

[] [CERTIFICATION I, Ping Chen, certify that: (1) I have reviewed this Annual Report on Form 10-K of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Zheng (Rita) Liu, certify that: (1) I have reviewed this Annual Report on Form 10-K of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company. March 31, 2010 Ping Chen Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company. March 31, 2010 Zheng (Rita) Liu Chief Financial Officer] [DEHAIER MEDICAL SYSTEMS LIMITED CHARTER OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS Purpose 1. The Audit Committee of Dehaier Medical Systems Limited (the “Company”) is appointed by the Board of Directors to assist the Board in fulfilling its oversight responsibilities by monitoring and reviewing: • The integrity of the Company’s financial reports and other financial information provided by]

By | 2016-03-25T09:34:55+00:00 March 31st, 2010|Categories: Chinese Stocks, DHRM, SEC Original|Tags: , , , , , |0 Comments
Read More

DHRM [Dehaier Medical Systems] 10-K:

[] [CERTIFICATION I, Ping Chen, certify that: (1) I have reviewed this Annual Report on Form 10-K of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Zheng (Rita) Liu, certify that: (1) I have reviewed this Annual Report on Form 10-K of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company. March 31, 2010 Ping Chen Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company. March 31, 2010 Zheng (Rita) Liu Chief Financial Officer] [DEHAIER MEDICAL SYSTEMS LIMITED CHARTER OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS Purpose 1. The Audit Committee of Dehaier Medical Systems Limited (the “Company”) is appointed by the Board of Directors to assist the Board in fulfilling its oversight responsibilities by monitoring and reviewing: • The integrity of the Company’s financial reports and other financial information provided by]

By | 2016-03-25T09:36:05+00:00 March 31st, 2010|Categories: Chinese Stocks, DHRM, Webplus ver|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-K: (Original Filing)

[FORM 10-K For the fiscal year ended December 31, 2009 OR For the transition period from ________________ to ________________ 001-15643YSTAR BIO-PHARMACEUTICALMPANY Nevada 33-0901534 (State or other jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian Province, P.R. China] [SERVICESREEMENT This SERVICESREEMENT (thisreement),ted of March 30, 2010, by and betweenystar Bio-Pharmaceuticalmpany, a Nevadarporation (thempany), and R.ott Cramer, an individual, whosedress is 1012 Lewis Drive Winter Park, Florida 32789-2225 (Consultant). Thempany and thensultant arellectively referred to herein the Parties.] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Bennet P. Tchaikovsky, certify that: 1. I have reviewed this annual report on Form 10-K ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer March 31, 2010] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Bennet P. Tchaikovsky Chief Financial Officer March 31, 2010] [Contract Registration No. 20096101021102 Technicaloperationreement Name of Project:operative Research of Party A: Xian Tianxing Bio-Pharmaceutical (stamp) Party B: Fourth Military Medical University (stamp) China Place of Execution: Xian, Shaanxi Province, Chinate of Effective: September 23, 2009 Term of Validity: From September 23, 2009 to thete when the performances under the terms of thereement aremplete.]

By | 2016-02-05T04:27:53+00:00 March 31st, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-K: FORM 10-K For the fiscal year ended December

[FORM 10-K For the fiscal year ended December 31, 2009 OR For the transition period from ________________ to ________________ 001-15643YSTAR BIO-PHARMACEUTICALMPANY Nevada 33-0901534 (State or other jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian Province, P.R. China] [SERVICESREEMENT This SERVICESREEMENT (thisreement),ted of March 30, 2010, by and betweenystar Bio-Pharmaceuticalmpany, a Nevadarporation (thempany), and R.ott Cramer, an individual, whosedress is 1012 Lewis Drive Winter Park, Florida 32789-2225 (Consultant). Thempany and thensultant arellectively referred to herein the Parties.] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Bennet P. Tchaikovsky, certify that: 1. I have reviewed this annual report on Form 10-K ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer March 31, 2010] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Bennet P. Tchaikovsky Chief Financial Officer March 31, 2010] [Contract Registration No. 20096101021102 Technicaloperationreement Name of Project:operative Research of Party A: Xian Tianxing Bio-Pharmaceutical (stamp) Party B: Fourth Military Medical University (stamp) China Place of Execution: Xian, Shaanxi Province, Chinate of Effective: September 23, 2009 Term of Validity: From September 23, 2009 to thete when the performances under the terms of thereement aremplete.]

By | 2016-02-05T04:28:51+00:00 March 31st, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar